- socially bharat
- January 10, 2025
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Beijing, China & Prague, Czech Republic: Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody